Impact of enzalutamide, an androgen receptor signaling inhibitor, on time to first skeletal related event (SRE) and pain in the phase 3 AFFIRM study Meeting Abstract
| Authors: | Fizazi, K.; Scher, H. I.; Saad, F.; Sternberg, C. N.; Miller, K.; Mulders, P.; Chi, K.; Basch, E.; Hirmand, M.; de Bono, J. S. |
| Abstract Title: | Impact of enzalutamide, an androgen receptor signaling inhibitor, on time to first skeletal related event (SRE) and pain in the phase 3 AFFIRM study |
| Meeting Title: | 37th Congress of the European Society for Medical Oncology (ESMO) |
| Journal Title: | Annals of Oncology |
| Volume: | 23 |
| Issue: | Suppl. 9 |
| Meeting Dates: | 2012 Sep 28-Oct 2 |
| Meeting Location: | Vienna, Austria |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2012-09-01 |
| Start Page: | ix295 |
| End Page: | ix296 |
| Language: | English |
| ACCESSION: | WOS:000309409001377 |
| PROVIDER: | wos |
| PUBMED: | 23012731 |
| DOI: | 10.1016/S0923-7534(20)33470-0 |
| Notes: | Meeting Abstract: 896O -- "Source: Wos" |
Altmetric
Citation Impact
BMJ Impact Analytics
